Wells Fargo & Company Timber Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.1 - $0.3 $49 - $147	492 Added 126.48%	881 $0
Q2 2022 Aug 12, 2022	BUY	$0.24 - $0.39 $7 - $12	32 Added 8.96%	389 $0
Q1 2022 May 16, 2022	BUY	$0.28 - $0.41 $46 - $68	166 Added 86.91%	357 $0
Q3 2021 Nov 15, 2021	SELL	$0.89 - $1.18 $7 - $9	-8 Reduced 4.02%	191 $0
Q2 2021 Aug 16, 2021	BUY	$1.06 - $2.25 $167 - $355	158 Added 385.37%	199 $0
Q1 2021 May 13, 2021	BUY	$0.81 - $3.55 $2 - $10	3 Added 7.89%	41 $0
Q3 2020 Nov 05, 2020	BUY	$0.92 - $2.4 $26 - $69	29 Added 322.22%	38 $0
Q2 2020 Aug 13, 2020	BUY	$2.16 - $6.95 $19 - $62	9 New	9 $0

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.